| # | Title | Journal | Year | Citations |
|---|
| 1 | The Future of Cancer Genomics | Clinical OMICs | 2014 | 25 |
| 2 | Promoting Wellness & Demystifying Disease: The 100K Project | Clinical OMICs | 2014 | 20 |
| 3 | BERG, Mass General, Brigham and Women's Collaborate to ID Alzheimer's Biomarkers | Clinical OMICs | 2018 | 7 |
| 4 | Kymriah, First CAR-T Cancer Immunotherapy Approved by FDA | Clinical OMICs | 2017 | 6 |
| 5 | NIH Begins COVID-19 Vaccine Booster Shot Trials | Clinical OMICs | 2021 | 6 |
| 6 | Wearable Data Revolution: Digital Biomarkers Are Transforming Research, Promising a Revolution in Healthcare | Clinical OMICs | 2019 | 5 |
| 7 | Ready for Prime Time?: AI Influencing Precision Medicine but May Not Match the Hype | Clinical OMICs | 2018 | 4 |
| 8 | Moderna's COVID-19 Vaccine Speeds to Phase III Trial After More Positive Data | Clinical OMICs | 2020 | 4 |
| 9 | The Biomarker Future is Digital | Clinical OMICs | 2020 | 4 |
| 10 | Lilly COVID-19 Antibody Combination Gets Emergency Use Authorization from FDA | Clinical OMICs | 2021 | 4 |
| 11 | Marking the Sweet Spot for Immunotherapies | Clinical OMICs | 2016 | 3 |
| 12 | Watson Recommends Incorrect Cancer Treatments, System Training Questioned | Clinical OMICs | 2018 | 3 |
| 13 | CRISPR Comes of Age—As a Diagnostic: Hailed for its gene editing power, Sherlock Bioscience's COVID-19 diagnostic is the first CRISPR technology to gain FDA approval | Clinical OMICs | 2020 | 3 |
| 14 | Novavax and Janssen Report Positive Phase III Results for COVID-19 Vaccine Candidates | Clinical OMICs | 2021 | 3 |
| 15 | NIH Launches Remdesivir Plus Interferon Beta-1a Trial for COVID-19 Treatment | Clinical OMICs | 2020 | 3 |
| 16 | Prostate Cancer: A Closer Look at Risk Factors | Clinical OMICs | 2016 | 2 |
| 17 | Data Deluge | Clinical OMICs | 2017 | 2 |
| 18 | Rocking the Baseline: Verily, Duke, and Stanford Aim to Make Medicine More Predictive with a New Baseline Study | Clinical OMICs | 2017 | 2 |
| 19 | AZ Partners with DNAnexus for 2 Million Patient Sequencing Project | Clinical OMICs | 2017 | 2 |
| 20 | Google's AI Tool DeepVariant Promises Significantly Fewer Genome Errors | Clinical OMICs | 2018 | 2 |
| 21 | THE 100,000 Genomes Club: 10 Countries Meet the Mark for National Genome Projects | Clinical OMICs | 2018 | 2 |
| 22 | Cognoa Wins FDA Class II Designation for AI-Based Autism Diagnostic | Clinical OMICs | 2018 | 2 |
| 23 | Right Person, Right Drug: Pharmacogenomics Makes Inroads to the Clinical Setting | Clinical OMICs | 2018 | 2 |
| 24 | AACR Project GENIE: Powering Precision Medicine Through Data Sharing: A Real-world Clinico-Genomic Registry for Clinical and Translational Discovery | Clinical OMICs | 2019 | 2 |
| 25 | Moving Beyond PCR: Next-generation sequencing enters the COVID-19 testing arena | Clinical OMICs | 2020 | 2 |
| 26 | NIH Launches COVID-19 Clinical Trial of Immune Modulators | Clinical OMICs | 2020 | 2 |
| 27 | Knome Automates Genome Interpretation | Clinical OMICs | 2014 | 1 |
| 28 | Exceptional Responders: The “N of 1” Paradigm | Clinical OMICs | 2014 | 1 |
| 29 | Myriad, AbbVie Expand Tumor BRACAnalysis CDx Collaboration | Clinical OMICs | 2014 | 1 |
| 30 | Early Detection: The Real Way to Beat Cancer | Clinical OMICs | 2014 | 1 |
| 31 | NIH Publishes Finalized Policy on Genomic Data Sharing | Clinical OMICs | 2014 | 1 |
| 32 | The Public Health Role in Translating Advances in Genomics | Clinical OMICs | 2014 | 1 |
| 33 | Real-Time PCR: Yet More Worlds to Conquer | Clinical OMICs | 2014 | 1 |
| 34 | Companion Diagnostics for Cancer: Will NGS Play a Role? | Clinical OMICs | 2015 | 1 |
| 35 | Could RNA Sequencing Become the Workhorse of Precision Medicine? | Clinical OMICs | 2015 | 1 |
| 36 | Clinical Actionability in Genomic Medicine | Clinical OMICs | 2015 | 1 |
| 37 | Pharmacogenomics Serves as the Critical Driver for Precision Medicine | Clinical OMICs | 2015 | 1 |
| 38 | Biomarkers and Cancer: Correlation Is Not Causation | Clinical OMICs | 2015 | 1 |
| 39 | Validating NGS-Based Genetic Tests | Clinical OMICs | 2015 | 1 |
| 40 | Cloudera Awards Five PMI Grants | Clinical OMICs | 2016 | 1 |
| 41 | From DNA to Diagnosis without Delay | Clinical OMICs | 2016 | 1 |
| 42 | A New Era Predicted for LC-MS in the Clinical Lab | Clinical OMICs | 2016 | 1 |
| 43 | Validating VOCs | Clinical OMICs | 2017 | 1 |
| 44 | Ring in the New: Rady Children’s Hospital Introduces NovaSeq for Newborn Diagnoses | Clinical OMICs | 2017 | 1 |
| 45 | Illumina to Integrate Watson for Genomics into BaseSpace Sequence Hub | Clinical OMICs | 2017 | 1 |
| 46 | Decoding the Dark Genome | Clinical OMICs | 2017 | 1 |
| 47 | DNAnexus, Saphetor Partner on Genomic Analysis Solution | Clinical OMICs | 2017 | 1 |
| 48 | Study Shows ctDNA Can Detect NSCLC Relapse Months Ahead of Standard Methods | Clinical OMICs | 2017 | 1 |
| 49 | Early Cancer Detection via ctDNA May Not Add Up | Clinical OMICs | 2018 | 1 |
| 50 | Exosomes Containing PD-L1 Could Predict Immunotherapy Responses: Immune-Evasion Mechanism May Help Explain the Differences in Responses to Immunotherapy | Clinical OMICs | 2018 | 1 |
